| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |